Biosimilar Newsletter Archive

1. 06.18.21 -- Risk Management In Biologics Combination Product Development 6/18/2021

   06/18/21 Biosimilar Development Newsletter

2. 06.17.21 -- Outlook: Biotech In 2021 & Beyond 6/17/2021
   06/17/21 Biosimilar Development Newsletter
3. 06.10.21 -- Latest On Purifying Cryo-EM Samples And Infectious Virus Particles 6/10/2021

   06/10/21 Biosimilar Development Newsletter

4. 06.10.21 -- Small-Scale Model Qualification For Upstream & Downstream Bioprocessing 6/10/2021
   06/10/21 Biosimilar Development Newsletter
5. 06.09.21 -- Exosomes' Therapeutic Potential, AAV and Lentiviral Gene Therapies, and more from the Business of Biotech Podcast 6/9/2021
   06/09/21 Biosimilar Development Newsletter
6. 06.07.21 -- Evolving Biosafety Testing To Meet The Needs Of Biologics Manufacturers 6/7/2021

   06/07/21 Biosimilar Development Newsletter

7. 06.03.21 -- Implementing Small-Scale Models For Biopharmaceutical Development 6/3/2021
   06/03/21 Biosimilar Development Newsletter
8. 06.02.21 -- Boost Your CHO Cell Line -- Find The Best Media & Feed 6/2/2021

   06/02/21 Biosimilar Development Newsletter

9. 05.27.21 -- Not A Time For Novices: FDA Needs This In A Leader 5/27/2021
   05/27/21 Biosimilar Development Newsletter
10. 05.25.21 -- Process Intensification: Best Practices For Implementing 5/25/2021

    05/25/21 Biosimilar Development Newsletter